Powe, D. G.
386  Ergebnisse:
Personensuche X
?
2

Nottingham prognostic index plus (NPI+) predicts risk of di..:

Green, Andrew R. ; Soria, D. ; Powe, D. G....
Breast Cancer Research and Treatment.  157 (2016)  1 - p. 65-75 , 2016
 
?
3

Erratum to: Nottingham prognostic index plus (NPI+) predict..:

Green, Andrew R. ; Soria, D. ; Powe, D. G....
Breast Cancer Research and Treatment.  159 (2016)  1 - p. 199-199 , 2016
 
?
9

Beta-blocker usage after malignant melanoma diagnosis and s..:

McCourt, C. ; Coleman, H.G. ; Murray, L.J....
British Journal of Dermatology.  170 (2014)  4 - p. 930-938 , 2014
 
?
11

Beta-blocker usage and breast cancer survival: a nested cas..:

Cardwell, Chris R ; Coleman, Helen G ; Murray, Liam J..
International Journal of Epidemiology.  42 (2013)  6 - p. 1852-1861 , 2013
 
?
13

Nonallergic Rhinitis-Identifying Gaps in Research:

Esteitie, R. ; Jones, N.S. ; Toskala, E....
Journal of Allergy and Clinical Immunology.  127 (2011)  2 - p. AB254-AB254 , 2011
 
?
14

Alpha- and beta-adrenergic receptor (AR) protein expression..:

Powe, D. G. ; Voss, M. J. ; Habashy, H. O....
Breast Cancer Research and Treatment.  130 (2011)  2 - p. 457-463 , 2011
 
?
15

O-37 SOX11 and PSMD3 expression in HER2 positive breast can..:

Pang, Y. ; Ball, G.R. ; Rakha, E.A....
European Journal of Cancer Supplements.  8 (2010)  6 - p. 14 , 2010
 
1-15